Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 01, 2020 10:18 ET | Source: Tempus

Tempus Launches Prospective “Priority” Research Study and Increases Support for Oncology Research Initiatives Despite Pandemic Challenges

CHICAGO, June 01, 2020 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, today announces its...
May 31, 2020 10:30 ET | Source: Tempus

Tempus Launches New Precision Medicine-Driven Tests: Tempus|HRD and Tempus|TO

CHICAGO, May 31, 2020 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, announced the launch...
May 30, 2020 10:30 ET | Source: Tempus

Tempus Launches COVID-19-Specific Clinical and Research Initiatives for Oncology

CHICAGO, May 30, 2020 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, introduced a series of...
May 29, 2020 15:55 ET | Source: Tempus

Tempus’ TIME Trial™ Program Reaches Critical Scale and Operational Milestones

CHICAGO, May 29, 2020 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, has reached a...
October 29, 2019 11:00 ET | Source: Tempus

Tempus Announces the Appointment of Scott Gottlieb, MD, to Its Board of Directors

CHICAGO, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, today announced that...
September 30, 2019 11:00 ET | Source: Tempus

Nature Biotechnology Study Reveals That Tempus’ xT Platform Increases Cancer Patients’ Personalized Therapeutic Opportunities

CHICAGO, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, today published a...
September 03, 2019 13:00 ET | Source: Tempus

Tempus Expands Its Management Team With the Appointment of Lauren Silvis as Senior Vice President of External Affairs

CHICAGO, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the collection and analysis of molecular and clinical data at scale, announced today the...
August 22, 2019 12:00 ET | Source: Tempus

Tempus Expands Leadership Team With the Appointment of Joel Dudley, PhD, as Senior Vice President of Research

CHICAGO, Aug. 22, 2019 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the collection and analysis of molecular and clinical data at scale, announces the...
June 11, 2019 08:00 ET | Source: Tempus

Tempus and Leidos Biomedical Research Inc. Launch Effort to Enhance The Cancer Genome Atlas

CHICAGO, June 11, 2019 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the collection and analysis of molecular and clinical data at scale announced today that...
June 03, 2019 10:30 ET | Source: Tempus

Tempus Announces (TIME) Trial Service, a New Integrated Molecular Evaluation that Leverages Artificial Intelligence to Rapidly Match Cancer Patients to Clinical Trials

CHICAGO, June 03, 2019 (GLOBE NEWSWIRE) -- Tempus, a technology company advancing precision medicine through the collection and analysis of molecular and clinical data at scale, announced today a...

Next Page keyboard_arrow_right